Raymond James & Associates’s Conformis, Inc. Common Stock CFMS Stock Holding History

Raymond James & Associates’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-440	Closed	-$7K	–	4282
2022 Q1	$7K	Sell	440 -4	-0.9%	-$66	﹤0.01%	4080
2021 Q4	$8K	Sell	444 -98	-18%	-$2.51K	﹤0.01%	4086
2021 Q3	$18K	Buy	542 +98	+22%	+$3.45K	﹤0.01%	4012
2021 Q2	$13K	Hold	444	–	–	﹤0.01%	4020
2021 Q1	$11K	Buy	+444	New	+$12K	﹤0.01%	3956
2017 Q4	–	Sell	-440	Closed	-$39K	–	3560
2017 Q3	$39K	Buy	+440	New	+$43.6K	﹤0.01%	3261
2016 Q4	–	Sell	-534	Closed	-$132K	–	3389
2016 Q3	$132K	Sell	534 -112	-17%	-$22.5K	﹤0.01%	2956
2016 Q2	$113K	Buy	+646	New	+$152K	﹤0.01%	2781

Other funds holding CFMS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's CFMS Position: Q2 2022 in Review

Raymond James & Associates sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2022, closing a stake of 440 shares — an estimated $7K sold.

Raymond James & Associates first reported a position in CFMS in Q2 2016 and held it in 8 quarters. The position peaked at $132K in Q3 2016. 81 funds tracked by Wall St. Rank hold CFMS as of Q2 2022.

Raymond James & Associates reported no remaining Conformis, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Raymond James & Associates sold 440 Conformis, Inc. Common Stock shares in Q2 2022, an estimated $7K.
Raymond James & Associates first reported a position in Conformis, Inc. Common Stock in Q2 2016 and held it in 8 quarters.
Raymond James & Associates's Conformis, Inc. Common Stock position peaked at $132K in Q3 2016.
81 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.